Dr. Fernando Reyes
Fernando Reyes received his Ph. D. in Organic Chemistry from the University of Granada (Spain) in 1995. In 1997, he started an 18 month post-doctoral stage with Prof. Chris Abell at the University of Cambridge (UK), focused on the synthesis of potential inhibitors of enzymes of the shikimate and pantothenate pathways. Over the last 17 years, he has worked on the isolation and structural elucidation of bioactive natural products from several biological sources and for different companies, including Smithkline Beecham and PharmaMar. His work in this last company during the period 2000-2010 was mainly dedicated to the isolation of bioactive metabolites from marine organisms.
From September 2010 he is Area Head of the Chemistry Department at Fundación MEDINA, where he leads a group of scientists working on isolation and structural characterization of bioactive metabolites from microbial sources, including actinomycetes and fungi. He has co-authored more than 60 scientific publications in the field of natural products chemistry and is co-inventor of 14 international patents, all of them on bioactive natural products. He is member of the editorial board of Marine Drugs and serves regularly as reviewer of several journals in the area of natural products.
Fundación MEDINA is a Research Organization established in the Health Sciences Technology Park, Granada (Spain) as a private-public partnership between the Government of Andalucía (Spain), the University of Granada and Merck Sharp and Dohme de España S.A. MEDINA is an independent and non-profit entity with innovative research collaborations and contracts with academic and industrial partners worldwide. We are engaged in the discovery of novel drug candidates and new biomarkers with Pharma and Biotech companies and research groups, as well as of new biotechnological products for use in crop protection for the Agrofood industry, Consumer products (Cosmetic and Nutrition) and new enzymes for industrial processes.
MEDINA owns one of the largest Collections of Microbial Strains and the most chemically diverse Natural Products Libraries with a longstanding, successful track record in delivering novel drug candidates for development as pharmaceuticals. Our team has unique expertise in microbiology, natural products chemistry, and high throughput screening, as well as a strong analytical chemistry platform for structural elucidation and bioanalysis. We are currently active in drug and biomarker discovery programs in infectious diseases (including tuberculosis and parasitic diseases), cancer, CNS, and rare diseases.